Aoti

Aoti Net Debt per Share

The Net Debt per Share of Aoti (AOTI.L) as of Nov 18, 2026 is 0.07 USD.

Net Debt per Share

0.07USD

YoY

-1,981.51%

Last updated:

Net Debt per Share of Aoti is 2025 0.07 USD. Net Debt per Share of Aoti was 2024 -0.00 USD. It decreases by -1,981.51% higher compared to the previous year.

The Aoti Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2021
-0.00 USD
Jan 1, 2022
0.09 USD
Jan 1, 2023
0.11 USD
Jan 1, 2024
-0.00 USD
Jan 1, 2025
0.07 USD
The Aoti Net Debt per Share history
YEARNet Debt per ShareYoY
0.07USD-1,981.51%
-0.00USD-103.56%
0.11USD+20.83%
0.09USD-33,867.75%
-0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aoti Stock analysis

What does Aoti do? Aoti Inc generates revenue through its wound care technology products, primarily TWO2 therapy and NEXA Negative Pressure Wound Therapy (NPWT). The company's TWO2 therapy solutions include TWO2 Extremity Chamber and TWO2 Multi-Patch, designed for patient-administered treatment of chronic wounds. NEXA NPWT System is a disposable, multi-week solution for wound care, targeting healthcare providers who manage chronic wound cases. Aoti focuses on enhancing access to care and improving clinical outcomes for patients with chronic conditions, leveraging robust clinical evidence to support its products' safety and efficacy. Healthcare providers and institutions purchasing TWO2 and NEXA systems form the primary customer segment, driven by the need for clinically proven wound care solutions. The company's products are positioned to address chronic wound management globally, with emphasis on patient quality of life and health equity. Aoti's business model centers on delivering evidence-based therapies that improve patient outcomes while meeting healthcare systems' demands for effective, efficient care delivery. The company's revenue streams are derived from direct sales of TWO2 and NEXA systems to healthcare facilities and practitioners. Product offerings are structured to support both acute and chronic wound care needs, with TWO2 being a multi-modality patient-administered therapy and NEXA providing a flexible, disposable NPWT system. Aoti's focus on clinical evidence ensures its solutions align with healthcare providers' requirements for safety and efficacy in wound treatment. Aoti is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aoti stock

Net Debt per Share of Aoti is 0.07 USD in 2025.

On Eulerpool you can find the complete historical development of Net Debt per Share Aoti since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Aoti

All Key Metrics — Aoti